U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07728487) titled 'Study of AT-587 in Healthy Subjects' on July 22.

Brief Summary: This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects

Study Start Date: July 13

Study Type: INTERVENTIONAL

Condition: Hepatitis E

Intervention: DRUG: AT-587

Parallel Assignment

OTHER: Placebo

Parallel Assignment

Recruitment Status: RECRUITING

Sponsor: Atea Pharmaceuticals, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....